These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7635037

  • 1. Lacidipine--a once-daily calcium antagonist for hypertension.
    Drug Ther Bull; 1994 Aug 18; 32(8):60-1. PubMed ID: 7635037
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Comparative study of lacidipine and nifedipine SR in the treatment of hypertension: an Italian multicenter study. The Northern Italian Study Group of Lacidipine in Hypertension.
    Leonetti G.
    J Cardiovasc Pharmacol; 1991 Aug 18; 17 Suppl 4():S31-4. PubMed ID: 1726003
    [Abstract] [Full Text] [Related]

  • 5. Lacidipine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of hypertension.
    Lee CR, Bryson HM.
    Drugs; 1994 Aug 18; 48(2):274-96. PubMed ID: 7527328
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Relative efficacy and tolerability of lacidipine and amlodipine in patients with mild-to-moderate hypertension: a randomized double-blind study.
    Lau CP, Cheung BM.
    J Cardiovasc Pharmacol; 1996 Aug 18; 28(2):328-31. PubMed ID: 8856491
    [Abstract] [Full Text] [Related]

  • 8. Calcium antagonist antihypertensive treatment of non-insulin-dependent diabetics: efficacy and safety of lacidipine versus nifedipine SR.
    Gulizia M, Valenti R, Platania F, D'Onofrio V, Rizzini P, Circo A.
    J Cardiovasc Pharmacol; 1994 Aug 18; 23 Suppl 5():S101-4. PubMed ID: 7609494
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Similarities and differences between calcium antagonists: pharmacological aspects.
    van Zwieten PA, Pfaffendorf M.
    J Hypertens Suppl; 1993 Mar 18; 11(1):S3-11. PubMed ID: 8483019
    [Abstract] [Full Text] [Related]

  • 12. Lacidipine. Aponil, Caldine, GR 43659, GR 43659X, GX 1048, Lacimen, Lacipil, Lacirex, Midotens, Motens, SN 305, Viapres.
    Drugs R D; 2002 Mar 18; 3(5):324-30. PubMed ID: 12455153
    [No Abstract] [Full Text] [Related]

  • 13. Cardiovascular advantages of a third generation calcium antagonist. Symposium on lacidipine. Foreword.
    Zanchetti A.
    Drugs; 1999 Mar 18; 57 Suppl 1():2 p preceding 1. PubMed ID: 10529077
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Clinical position of lacidipine, a new dihydropyridine calcium antagonist, in the treatment of hypertension.
    Leonetti G.
    J Cardiovasc Pharmacol; 1991 Mar 18; 18 Suppl 11():S18-21. PubMed ID: 1725445
    [Abstract] [Full Text] [Related]

  • 17. Semipersonalized psychological evaluation of quality of life in hypertensive patients during a trial with two calcium antagonists: a multicenter Latin-American Study (LASTLHY).
    Velasco M, Lezama E, Hernández-Hernández R, Armas-Hernández MJ, Armas-Padilla MC, Alcocer L.
    Int J Clin Pharmacol Ther; 2001 Aug 18; 39(8):325-30. PubMed ID: 11515706
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of lacidipine, a long-acting calcium antagonist, on hypertension and lipids: a 1 year follow-up.
    Soro S, Ferrara LA.
    Eur J Clin Pharmacol; 1991 Aug 18; 41(2):105-7. PubMed ID: 1743241
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.